SEC Filing Document

Company: Jones Ventures INTL Acquisition1 Corp
Ticker: 
CIK: 2129056
Filing Type: S-1
Document Type: EX-1.1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057072
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2129056/000121390026057072/ea028579202ex1-1.htm

Chunk 19 of 22
Word Count: 1211
Character Count: 7681

Document Content:

effect regardless of any investigation made by or on behalf of the Underwriters, the Company or any controlling person, and shall survive termination of this Agreement or the issuance and delivery of the Public Securities to the Underwriters until the earlier of the expiration of any applicable statute of limitations and the seventh (7th) anniversary of the later of the Closing Date or the Option Closing Date, if any, at which time the representations, warranties and agreements shall terminate and be of no further force and effect. Charter Documents. The Company shall not take any action or omit to take any action that would cause the Company to be in breach or violation of any of its Charter Documents. Effective Date of This Agreement and Termination Thereof. Effective Date. This Agreement shall become effective on the Effective Date at the time the Registration Statement is declared effective by the Commission.

Termination. The Representative shall have the right to terminate this Agreement at any time prior to the Closing Date by notice
given to the Company, (i) if any domestic or international event or act or occurrence has materially disrupted, or in the Representative’s
opinion will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if trading on the New
York Stock Exchange (“NYSE”), the NYSE American, The Nasdaq Global Select Market, The Nasdaq Global Market, or The
Nasdaq Capital Market or quotation on the OTCBB shall have been suspended, or minimum or maximum prices for trading shall have been fixed,
or maximum ranges for prices for securities shall have been fixed, or maximum ranges for prices for securities shall have been required
by FINRA or by order of the Commission or any other government authority having jurisdiction; or (iii) if the United States shall have
become involved in a new war or a significant increase in existing major hostilities; or (iv) if a banking moratorium has been declared
by a New York State or Federal authority; or (v) if a moratorium on foreign exchange trading has been declared which materially adversely
impacts the United States securities market; or (vi) if the Company shall have sustained a material loss by fire, flood, accident, hurricane,
earthquake, theft, sabotage or other calamity (including, without limitation, a calamity relating to a public health matter or natural
disaster) or malicious act which, whether or not such loss shall have been insured, will, in the Representative’s opinion, make
it inadvisable to proceed with the delivery of the Units; or (vii) if the Company is in material breach of any of its representations,
warranties or covenants hereunder; or (viii) if the Representative shall have become aware after the date hereof of such a material adverse
change in the conditions of the Company, or such adverse material change in general market conditions, including without limitation,
as a result of terrorist activities or any other calamity (including, without limitation, a calamity relating to a public health matter
or natural disaster) or crisis either within or outside the United States after the date hereof, or a significant increase in any of
the foregoing, as in the Representative’s judgment would make it impracticable to proceed with the offering, sale and/or delivery
of the Units or to enforce contracts made by the Underwriters for the sale of the Public Securities.

Expenses. In the event that this Agreement shall not be carried out for any reason other than solely because of the termination
of this Agreement pursuant to Section 6 hereof, within the time specified herein or any extensions thereof pursuant to the terms
herein, (i) the obligations of the Company to pay the out of pocket expenses related to the transactions contemplated herein shall be
governed by Section 3.10 hereof and (ii) the Company shall reimburse the Representative for any reasonable and documented out-of-pocket
costs and expenses incurred in connection with enforcing any provisions of this Agreement.

Indemnification. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination
of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall not be in any
way affected by such election or termination or failure to carry out the terms of this Agreement or any part hereof.

Miscellaneous.

Notices. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed,
delivered by hand or reputable overnight courier or delivered by facsimile or electronic transmission (with printed confirmation of receipt)
and confirmed and shall be deemed given when so emailed, delivered or faxed or if mailed, two days after such mailing.

to the Representative:

JonesTrading
Institutional Services LLC

JonesTrading Institutional Services LLC

325 Hudson Street, 6th Floor

New York, New York 10013

Attn:

Email:

Copy
(which copy shall not constitute notice) to:

Ellenoff
Grossman & Schole

Avenue of the Americas

New
York, New York 10105

Attn:
Stuart Neuhauser, Esq.

Facsimile:

Email:
sneuhauser@egsllp.com

to the Company:

Jones
Ventures INTL Acquisition1 Corp

c/o JonesTrading Institutional Services LLC

325 Hudson Street, 6th Floor

New York, New York 10013

Attn:
Alan F. Hill, Chief Executive Officer

Email:

Copy
(which copy shall not constitute notice) to:

King
& Spalding LLP

1290 Avenue of the Americas

New York, New York 10104

Attn: Kevin E. Manz, Esq.

Email: kmanz@kslaw.com

Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Agreement.

Amendment. This Agreement may only be amended by a written instrument executed by each of the parties hereto.

Entire Agreement. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
supersede all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

Binding Effect. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters,
the Company and the controlling persons, directors, agents, partners, members, employees and officers referred to in Section 5
hereof, and their respective successors, legal representatives and assigns, and no other person shall have or be construed to have any
legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The
term “successors and assigns” shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.

Waiver of Immunity. To the extent that the Company may be entitled in any jurisdiction in which judicial proceedings may at any
time be commenced hereunder, to claim for itself or its revenues or assets any immunity, including sovereign immunity, from suit, jurisdiction,
attachment in aid of execution of a judgment or prior to a judgment, execution of a judgment or any other legal process with respect
to its obligations hereunder and to the extent that in any such jurisdiction there may be attributed to the Company such an immunity
(whether or not claimed), the Company hereby irrevocably agrees not to claim and irrevocably waives such immunity to the maximum extent
permitted by law.